Skip to content
TrialScanner

NCT03149549

PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors

Phase 1/Phase 2TerminatedCTMXLead

Registry record

Lead sponsor
CytomX Therapeutics
Conditions
Solid Tumor, Adult; Breast Cancer; Non Small Cell Lung Cancer; Head and Neck Cancer; Ovarian Cancer
Primary completion
Sep 10, 2020Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT03149549 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT03149549: PROCLAIM-CX-2009: A Trial to... | TrialScanner